Many people who want to come off a benzodiazepine begin on a medication that is hard to taper directly. Alprazolam and lorazepam leave the body quickly. As the level in the bloodstream rises and falls through the day, comfort tends to come and go with it, which makes a steady, gradual reduction hard to achieve. Clonazepam lasts longer than those two, but it is so potent that even its smallest tablet represents a large step, and cutting it into the tiny reductions a slow taper needs is difficult.
Physical dependence on a prescribed benzodiazepine is not addiction. It is the expected result of regular use, and a slow taper exists to unwind it.
The Ashton Manual offers a well-known answer to both problems. Rather than tapering directly from the original medication, it describes a crossover to diazepam, a long-acting benzodiazepine that comes in small dose forms, and then a slow reduction from there. This guide walks through that method step by step, in plain language, so the logic behind each stage is clear before any change begins.
Why a longer-acting medication helps.
A longer-acting medication clears the body slowly. Because of this, its level in the bloodstream stays much steadier across the day instead of climbing and falling sharply. Professor Ashton notes in Chapter 2 of the manual that diazepam needs to be taken at most twice a day to keep its blood level smooth, where a short-acting drug has to be dosed several times a day and still dips in between.
With a short-acting drug, the body experiences something like small repeated dips between doses. Each dip can feel like a return of discomfort, and the next dose only brings temporary relief. This pattern makes it hard to tell whether a reduction is being tolerated or not.
Diazepam smooths that pattern out. Its slow, even presence means the body is not riding a wave up and down throughout the day, so each small reduction is felt more gently and more predictably. For people starting from alprazolam or lorazepam, that steadiness is the main reason the switch makes tapering smoother. For people starting from clonazepam, the reason is different: a small amount of clonazepam equals a much larger amount of diazepam, and diazepam comes in tablets small enough to halve, so the reductions that follow can be far finer than clonazepam tablets allow.
The goal of the crossover is to move from an uneven starting point to a level one, so that the reductions that follow can be small, regular, and far easier to manage.
The idea of equivalent substitution.
The crossover rests on a simple concept called equivalent substitution. Every benzodiazepine has a certain strength, and a given amount of one drug has a comparable effect to a certain amount of another. Table 1 in Chapter 1 of the Ashton Manual provides a chart of these rough equivalents so that a switch keeps the overall effect roughly the same.
This matters because the aim during the switch is stability, not reduction. The crossover and the taper are two separate jobs. First the medication is changed while the total effect stays steady, and only afterward does the dose begin to come down.
Thinking in shares of the day helps. Instead of focusing on numbers, it helps to picture the full daily amount as a whole made up of parts. Each part of the original medication has an equivalent share of diazepam that can take its place.
It also helps to remember that these equivalents are approximate, not exact. The chart in the Ashton Manual offers a reasonable starting point, and small adjustments are expected as a person learns how their own body responds. The equivalents guide the plan. They do not lock it.
Getting the conversion right matters in both directions. Too little diazepam can leave a person in withdrawal during the switch, while too much can cause oversedation. That is why the conversion is worked out by a physician rather than read straight off the chart.
When the equivalence is respected, the body should not notice a sudden change in effect during the switch. The intent is for the transition itself to feel like standing still, which is what makes the later reductions possible without a jarring shift.
Replacing one portion at a time.
The crossover is not done all at once. The Ashton Manual describes replacing the original medication gradually, one portion at a time, while the rest stays the same. This staged approach is what makes the switch gentle.
A common way to begin is to substitute a single portion of the daily medication with its diazepam equivalent, while leaving the remaining portions unchanged. Often the portion that comes off first is one of the daily segments rather than the whole amount, so the change is small and contained.
After that first substitution, the next step is simply to wait and observe. The body is given time to settle at the new arrangement before anything else is altered. There is no rush, and steadiness is the only thing being measured at this point.
Once that portion feels stable, the next portion of the original medication is replaced with its diazepam equivalent, again followed by a period of settling. This repeats, portion by portion, until the original drug has been fully exchanged for diazepam.
Working in portions has a quiet advantage. Because only one part of the daily amount changes at a time, any reaction is small and easy to read, and the rest of the medication stays familiar and unchanged. The crossover stays gentle precisely because it is broken into manageable pieces.
Stabilizing before moving on.
Stabilizing is a stage in its own right. Between each substitution, and again once the crossover is complete, the plan allows the body to find an even baseline at the new arrangement.
What stability looks like is a sense that the days have leveled out, without the sharp ups and downs that a short-acting medication tended to produce. When the day feels more uniform, that is the signal the crossover is doing its job.
It is worth knowing that diazepam can take some time to build up to its steady, even presence in the body. Because of this, relief from the switch is not always immediate, and there are clear reasons why diazepam may start working later rather than right away. Patience during this window is part of the method, not a sign that something is wrong.
Holding at a stable point also serves the taper that follows. A level starting place gives the reductions ahead a calm beginning, so that each small step down starts from comfort rather than from a place that already feels uneven.
Beginning the gradual reduction.
Once the crossover is complete and the days feel steady, the second job begins, which is reducing the diazepam itself. This is where the careful work of the switch pays off, because now there is only one medication to lower, and it is the slow, even kind.
The reductions are small and regular. Rather than large cuts spaced far apart, the method favors gentle steps taken at a comfortable pace, with a period of settling after each one. The body is allowed to adjust to each new level before the next step is considered.
A helpful way to picture this, though no analogy is perfect, is a long, shallow staircase rather than a short, steep one. Each step is modest enough that it can be absorbed without a sharp change in how the days feel, and the descent as a whole is slow and unhurried.
The pace is set by comfort, not by a calendar. If a step needs more time before the next one, the schedule bends to fit the person rather than the other way around. That flexibility follows from what is being treated. A person who has become physically dependent on a prescribed benzodiazepine has a medical condition caused by the medication, and the treatment for it is a gradual medical taper paced by the body rather than by a fixed timetable.
It is also normal for the right pace to change over the course of a taper. Early steps may feel straightforward, while later ones call for more patience and longer holds. Reading those signals and slowing down when needed is part of doing the method well, not a departure from it.
The logic of hyperbolic reductions.
As the dose gets lower, the reductions shift toward what are often called hyperbolic reductions. The basic idea is that the size of each cut shrinks as the total amount shrinks, so that the reductions are figured in proportion rather than in fixed amounts.
This proportional thinking matters because the lower end of a taper can be more sensitive than the beginning. Cutting the same fixed amount near the end represents a much larger share of what remains, so the same step that felt easy early on can feel much steeper later.
By making each reduction a smaller proportion as the dose falls, the felt size of each step stays roughly even all the way down. The math changes, but the experience aims to stay consistent and manageable from the first step to the last.
Approaching the very end this way, with smaller and smaller proportional cuts, lets the final stretch be as gentle as the rest. The taper does not speed up near the finish. If anything, the steps grow finer so the close feels as smooth as the start.
The proportional framing comes from the Maudsley Deprescribing Guidelines, which describe reductions as a shrinking fraction of the current dose. The Ashton Manual’s own schedules in Chapter 2 are written in fixed milligram steps, but those steps get smaller as the dose falls, so the two approaches are compatible in practice. Thinking in proportions lets a person plan the whole descent in a way that keeps the felt effort steady, which removes much of the worry that the end will be harder than the beginning.
When the method needs adjusting.
No single plan fits every person perfectly, and the Ashton method is meant to be adapted. The proportions, the pace, and the length of each settling period can all be shaped to fit how a given person responds.
For some, the crossover brings the steady relief it is designed to provide, and the taper proceeds in calm, even steps. For others, the picture is more complicated, and it helps to understand what to do when the crossover does not provide relief as expected.
Adjusting the method is part of the method. The framework gives structure, and within that structure there is wide room to slow down, hold longer, or revise the proportions to keep the days steady.
The measure of success is always the same. When the days feel level and each step can be absorbed without a sharp change, the method is doing its job, regardless of how the specific timing has been tailored.
When crossing over is not the right choice.
The diazepam crossover suits many people, but it is not universal. Some people have a metabolism that processes diazepam too quickly or too slowly for it to work well, and some have had an adverse reaction to diazepam or a related benzodiazepine in the past. In these cases, a same-medication taper using the person’s current benzodiazepine may be the better path.
For people who cannot use diazepam, careful tapering from clonazepam itself remains possible, using the same principles of gradual, proportional reduction, often with a liquid or compounded preparation to make the small steps measurable. There is more on what to do when diazepam does not work for a given person. These exceptions are why the crossover should be guided by a physician who can evaluate the individual, since the plan has to match the person.
Why not simply taper from clonazepam directly?
Some readers wonder why they cannot just taper from clonazepam without the extra step of crossing over. It is a reasonable question, and direct tapering is sometimes done.
Clonazepam does last longer than alprazolam or lorazepam, though not as long as diazepam. Professor Ashton notes in Chapter 2 that it is eliminated much faster than diazepam, which makes a smooth, slow fall in blood level harder to arrange. The larger difficulty, though, is potency and dose forms. A fraction of a milligram of clonazepam corresponds to a considerably larger amount of diazepam, so even half of the smallest clonazepam tablet is, in diazepam terms, several times the step that a halved diazepam tablet gives. Each reduction from clonazepam tablets is therefore coarser than it looks.
Crossing over from clonazepam to diazepam first turns those coarse steps into fine ones before the taper even begins. For many people that is the whole reason for the switch: it sets up a starting point from which the reductions can be as small as the body needs them to be.
A steady path forward.
From a stable base, the taper itself becomes a series of small, proportional steps down a long and shallow staircase. Each step starts from comfort, and the pace follows the person rather than a fixed schedule.
Understood this way, the method is less a leap and more a patient sequence of small, manageable moves, worked out with a physician who knows how your body has responded so far.
This article is educational. It is not medical advice, and reading it does not create a doctor-patient relationship. Decisions about starting, continuing, or tapering any medication should be made with your own physician.